As a Free StocksGuide user, you can view scores for all 7,075 stocks worldwide.
30 Analysts have issued a Exact Sciences Corporation forecast:
30 Analysts have issued a Exact Sciences Corporation forecast:
| Sep '25 |
+/-
%
|
||
| Revenue | 3,082 3,082 |
14%
14%
|
|
| Gross Profit | 2,076 2,076 |
6%
6%
|
|
| EBITDA | 63 63 |
155%
155%
|
|
| EBIT (Operating Income) EBIT | -155 -155 |
26%
26%
|
|
| Net Profit | -987 -987 |
361%
361%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
EXACT Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI.
| Head office | United States |
| CEO | Kevin Conroy |
| Employees | 6,950 |
| Founded | 1995 |
| Website | www.exactsciences.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


